⌘K

Login Start Free

Home/Filings/4/0000899243-22-024204

4//SEC Filing

Sullivan Eric 4

Accession 0000899243-22-024204

CIK 0001750019other

View on SEC.gov Company Profile

Filed

Jun 26, 8:00 PM ET

Accepted

Jun 27, 5:18 PM ET

Size

5.3 KB

Accession

0000899243-22-024204

Insider Transaction Report

Form 4

Period: 2022-06-27

TCR2 THERAPEUTICS INC.TCRR

Chief Financial Officer

Transactions

Award
Stock Option (Right to Buy)
2022-06-27+250,000→ 250,000 total
Exercise: $2.89Exp: 2032-06-27→ Common Stock (250,000 underlying)

Footnotes (1)

[F1]25% of this option shall vest and become exercisable on June 27, 2023, with the remainder vesting in thirty-six 36 equal monthly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

TCR2 THERAPEUTICS INC.

CIK 0001750019

Entity typeother

Related Parties

1

filerCIK 0001601797

Filing Metadata

Form type: 4
Filed: Jun 26, 8:00 PM ET
Accepted: Jun 27, 5:18 PM ET
Size: 5.3 KB

View on SEC.gov